JASON E ROTH

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SPOKANE, WA NPI 1316900665

General Payments — all program years on this page

$709.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $264.71 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $264.7113

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $196.8411
2020 $79.064
2021 $28.362
2023 $140.342
2024 $264.7113

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086202929 Bayer Healthcare Pharmaceuticals Inc. $13.60 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087344839 Novartis Pharmaceuticals Corporation $27.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087344851 Novartis Pharmaceuticals Corporation $22.98 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087344857 Novartis Pharmaceuticals Corporation $20.78 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087344859 Novartis Pharmaceuticals Corporation $19.72 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087344861 Novartis Pharmaceuticals Corporation $25.08 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101659693 E.R. Squibb & Sons, L.L.C. $26.35 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105443756 AstraZeneca Pharmaceuticals LP $16.19 10/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111692940 Amgen Inc. $16.15 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117961318 Boehringer Ingelheim Pharmaceuticals, Inc. $18.26 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117961320 Boehringer Ingelheim Pharmaceuticals, Inc. $18.74 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117961322 Boehringer Ingelheim Pharmaceuticals, Inc. $19.24 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141586714 Merck Sharp & Dohme LLC $19.76 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.